The top 10 biopharma stock gainers and losers for the week.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aimmax, Carsgen, Chiesi, Formosa.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Acorda, Adimune, Aditxt, Araris, Boehringer Ingelheim, Chance, Cyclica, Ginkgo, Lundbeck, Neuro3, Recursion, Scisparc, Selecta, TFF, Valence.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: ABM, Fibrogen, Golden.

Biopharmas raising money in public or private financings, including: Galmed, Morphic, Onkai.

New hires and promotions in the biopharma industry, including: Acelink, Aprea, Clearmind, Frontier Medicines, Inceptor, Incyte, Laronde.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Cumulus Neuroscience, Norlase, Nucleix.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Insulet, Tidepool.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Dermasensor, Know Labs.

Med-tech firms raising money in public or private financings, including: Augment Therapy, Opgen, Soligenix.